Building an agent workflow? Use the
public VC News MCP and WebMCP guide
to query source-linked rounds, company funding histories, and investor shortlists.
Salesforce agreed to buy Braze for about $5.66B enterprise value at $47.50 per share. A sourced look at the 58% premium, Braze's growth, VC investors, acquisition logic and closing risks.
A financial and strategic look at Slack five years after its $27.7B sale: historical revenue, GAAP profits, unit economics, retention, Salesforce integration and current Microsoft Teams, Zoom and Google Chat competition.
Compare 2026 quantum computing funding rounds and the companies behind them, from Oratomic and OQC to QuantrolOx. Distinguish equity, acquisitions and government support.
IBM completed its HRL Laboratories acquisition in August 2026. The price was undisclosed—not $237B. Here's what its silicon-spin expertise changes for the quantum industry.
Tin Men led Ailytics’ $7.4M Series A. Safie’s named trials show the workflow behind its Japan expansion—and why alerts alone don’t establish safer worksites.
Jolt led Phononic Vibes’ roughly $28M growth and secondary deal. Deutsche Bahn’s own evidence shows why better noise barriers can still carry a higher panel price.
OpenAI bought Orchestra Bio, but for how much? What its $20M historical funding means, who invested, how its drug-development agents work and why Rosalind matters.
Sapphire led Tractian’s $130M Series D. Its bet: proprietary machine data and better maintenance decisions can turn industrial AI into repeatable savings.
Blank Street's August 2026 financing was $105M including $75M primary and $30M secondary. Why the $650M valuation, General Atlantic and West Coast rollout matter.
Urban Innovation Fund led Pennant’s announced $5M seed. How its proxy-voting research works, where people stay involved and what its funding figures leave unclear.
Kevel announced $52M in financing. How its retail-media infrastructure works, what MC and Tesco illustrate, and why the funding should not be treated as all equity.
Summit led Cognitive Credit’s $40M growth investment. We explain its analyst workflow, subscription business and the limits of source-linked financial AI.
Mischief led BOB’s $5.5M seed. Its AI finance assistant is free because banking income pays for the software—a model that still needs to prove its economics.
OrbiMed and Janus Henderson co-led Star Therapeutics’ $200M private financing after the Vega sale. What the new preclinical pipeline still has to prove.
Thomvest led Coast's growth-equity round as Intuit Ventures joined. The fleet-finance platform is adding vendor payments, with separate pricing and a bigger adoption test.
Index and Lux co-led the AI lab's $1B Series A. Here is its chip-efficiency strategy, the reported $6B valuation and the commercial proof still needed.
Future Ventures led Xona's $250M Series D. Its Pulsar network is moving toward customer service, with farm-robot tests showing both the opportunity and the work ahead.
Formic’s $50M package combines Series B equity and debt. A customer case explains its robot subscriptions—and the equipment and service costs behind them.
Sequoia led Blacksmith's $66M Series C. A Clerk case study, usage-based economics and competing CI investments explain the bet on testing AI-generated code.
General Catalyst’s Customer Value Fund is backing Otter’s enterprise expansion. The capital avoids new equity dilution, but comes with repayment costs.
The sodium-ion battery company is preparing a U.S. factory and expanding toward data centers. The next test is turning customer orders into deliveries.
Pigment raised $250M at a $2.3B valuation. A hiring-budget example explains its planning software, ARR disclosure and why NVIDIA's investment remains described as planned.
Spark Capital led ASI's $325M Series C at a $3B valuation. Contract scale supports the critical-infrastructure AI thesis, but awards, recognized revenue, and durable margins are different measures.
Origin Ventures led VECKTA's $11M Series A. Its onsite-energy platform faces tests in project conversion, buyer trust, recurring revenue, and procurement economics.
Mural raised a $15M Series A, bringing total funding to $28M. A simple payment example explains its product, agent controls and what its volume figures mean.
Ara Energy Fund I reached final close with $1.8B in commitments and over $700M of separate co-investment. We examine the structure and operating risks.
Daytona raised $60M at a $1B valuation. A practical agent workflow explains its sandboxes, alternatives and the revenue figures it has—and hasn't—disclosed.
Whop's $200M Series D values it at $5.1B. What does Whop actually sell, how does it earn money, and why did Sequoia invest? A simple guide to the real numbers.
Different raised a $48M seed led by General Catalyst. Real Descope and Motif workflows explain what its marketing software does, what it keeps and what remains unproven.
B Capital and Kindred Ventures led Dream Labs' $90M seed round. Its research-beta API faces tests in task reliability, deployment costs and compute economics.
Playground Global led XRlabs' $8.4M seed round. The investment case turns on clinical evidence, repeatable integrations and hospital deployment economics.
Probably Genetic’s reported $12M Series A backs rare-disease data. We separate venture financing from research support and examine data quality and partner economics.
Vessla’s $3.3M pre-seed backs AI agents for property operations. The investment test is reliable handoffs, human approvals and repeatable integration economics.
Prism Data’s $20M Series A backs cash-flow underwriting. The investment test is production adoption, reliable transaction inputs and measurable lending outcomes.
Tolan’s $30M financing backs a persistent AI companion. We examine the investors, undisclosed terms and the retention, trust and compute-cost trade-off.
Town’s $108M Series B backs AI assistants that work across teams. The investment test is permission control, durable team adoption and cost per completed workflow.
Nouscom’s $135M Series D backs a registration-enabling trial of investigational NOUS-209. The funding is confirmed; clinical success remains to be demonstrated.
Tenstorrent’s $1.5B Series E values it at $6.2B post-money. The next test is manufacturing scale, usable software and repeat deployment of Galaxy servers.
Even Healthcare’s reported $50M Series B backs Bengaluru hospital expansion. The key test is whether managed care can scale with sustainable hospital economics.
Allswell’s $7M seed backs LGBTQ+ behavioral care expansion. The investment case depends on clinician capacity, payer access and reimbursement—not funding alone.
Genesys confirmed a second close adding Sunnybrook and UHN as hospital partners. The incremental amount is undisclosed; the story is the research-to-seed pathway.
Pantera led Fission’s $10M Series A. The investment case turns on liquidity capacity, pricing and eligibility—not just faster tokenized-fund transfers.
Industrifonden and Nordic Foodtech VC led OlsAro’s seed round. Field repeatability and seed-company execution are the next tests for its crop-genetics platform.
b2venture led Ambio’s seed round. Its principal model puts quality assurance and working-capital discipline at the centre of scaling recycled plastics procurement.
Othello’s $8M seed backs AI guidance during sales calls. Latency matters, but accuracy, adoption and controlled outcome evidence will decide its value.